India to France: Irbesartan Export Trade Route

The India to France Irbesartan corridor is one of India's established pharmaceutical export routes, with 327 shipments documented worth a combined $16.4M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 60% of all export value, reflecting the consolidated nature of India's irbesartan manufacturing sector.

Across 8 active suppliers, the average shipment value stands at $50.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with irbesartan's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 29.9%, placing it at rank #19 among India's top irbesartan export destinations globally.

On the import side, key buyers of Indian irbesartan in France include CSP VIATRIS SANTE AT CSP- LAB,, CSP Mylan SAS at CSP- Labo 274, , ARROW GENERIQUES, and 26 others. CSP VIATRIS SANTE AT CSP- LAB, is the single largest importer with 37 shipments valued at $5.8M USD.

India's irbesartan exports to France are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 107 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in France benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, MYLAN LABORATORIES LIMITED , AUROBINDO PHARMA LTD — together account for 86% of total trade value on this route. The average shipment value of $50.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines, irbesartan / hydroch and irbesartan / hydrochlorothiazide mylan 3, suggesting that buyers in France tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CSP VIATRIS SANTE AT CSP- LAB, is the largest importer with 37 shipments worth $5.8M USD — representing 35% of all irbesartan imports from India on this route. A total of 29 buyers are active on this corridor.